Drug Information Analysis Service

Yee GC McGuire TR . Pharmacokinetic drug interactions with cyclosporine (part 1). Clin Pharmacokinet 1990; 19: 319–32.

Baciewicz AM . BACIEWICZ FA Jr. Cyclosporine pharmacokinetic drug interactions. Am J Surg 1989; 157: 264–71.

Ptachcinski RJ Carpenter BJ Burckart GJ Venkataramanan R Rosenthal JT . Effect of erythromycin on cyclosporine levels (letter). N Engl J Med 1985; 313: 1416–7.

Vereerstraeten P Thiry P Kinnaert P Toussaint C . Influence of erythromycin on cyclosporine pharmacokinetics. Transplantation 1987; 44: 155–6.

Murray BM Edwards L Morse GD Kohli RR Venuto RC . Clinically important interaction of cyclosporine and erythromycin. Transplantation 1987; 43: 602–4.

Jensen CB Flechner SM Van Buren CT , Exacerbation of cyclosporine toxicity by concomitant administration of erythromycin. Transplantation 1987; 43: 263–7.

Wadhwa NK Schroeder TJ O'Flaherty E , Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient. Ther Drug Monit 1987; 9: 123–5.

Gupta SK Bakran A Johnson RWG Rowland M . Cyclosporin-erythromycin interaction in renal transplant patients. Br J Clin Pharmacol 1989; 27: 475–81.

Hourmant M Lebigot JF Vermillet L Sagniez G Remi JP Soulillou JP . Coadministration of erythromycin results in an increase of blood cyclosporine to toxic levels. Transplant Proc 1985; 17: 2723–7.

Freeman DJ Martell R Carruthers SG Heinrichs D Keown PA Stiller CR . Cyclosporin-erythromycin interaction and normal subjects. Br J Clin Pharmacol 1987; 23: 776–8.

Braunwald E Isselbacher KJ Petersdorf RG Wilson JD Martin JB Fauci AS , eds. Harrison's principles of internal medicine. 11th ed. New York: McGraw-Hill, 1987: 2109–10.

Dunagan W Ridner M , eds. Manual of medical therapeutics. 26th ed. Boston: Little, Brown, 1989: 482–503.

Sellers EM Zilm DH Degani NC . Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 1977; 33: 2096–108.

Mefford I . Ethanol and brain epinephrine. Ann Intern Med 1987; 107: 877–80.

Horwitz RI Gottlieb LD Kraus ML . The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Arch Intern Med 1989; 149: 1089–93.

Kraus ML Gottlieb LD Horwitz RI Anscher M . Randomized clinical trial of atenolol on patients with alcohol withdrawal. N Engl J Med 1985; 313: 905–9.

Scott R . Atenolol for alcohol withdrawal (letter). N Engl J Med 1986; 314: 782.

Liskow B Reed J . Atenolol for alcohol withdrawal (letter). N Engl J Med 1986; 314: 783.

Bodey GP Buckley M Sathe YS Freireich EJ . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–40.

Gabrilove JL . Introduction and overview of hematopoietic growth factors. Semin Hematol 1989; 26 (suppl 2): 1–4.

Morstyn G Burgess AW . Hemopoietic growth factors: A review. Cancer Res 1988; 48: 5624–36.

Garnick MB O'Reilly RJ . Clinical promise of new hematopoietic growth factors. Hematol Oncol Clin North Am 1989; 3: 495–509.

Weisbart RH Golde DW . Physiology of granulocyte and macrophage colony stimulating factors in host defense. Hematol Oncol Clin North Am 1989; 3: 401–9.

Mitsuyasu RT Golde DW . Clinical role of granulocyte-macrophage colony-stimulating factor. Hematol Oncol Clin North Am 1989; 3: 411–25.

Andreeff M Welte K . Hematopoietic colony-stimulating factors. Semin Oncol 1989; 16: 211–29.

Antman KS Griffin JD Elias A , Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988; 319: 593–8.

Herrmann F Schulz G Wieser M , Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Am J Med 1990; 88: 619–24.

Gianni AM Bregni M Siena S , Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 1990; 8: 768–78.

Logothetis CJ Dexeus FH Sella A , Escalated therapy for refractory urothelial tumors: Methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor. J Natl Cancer Inst 1990; 82: 667–72.

Steward WP Scarffe JH Dirix LY , Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer. Br J Cancer 1990; 61: 749–54.

Estey EH Dixon D Kantarjian HM , Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1990; 75: 1766–9.

Buchner TH Hiddemann W Zuhlsdorf M , Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemia in aplasia and at high risk of early death. Behring Inst Mitt 1988; 83: 308–12.

Devita VT . Principles of chemotherapy. In: DeVita VT Hellman S Rosenberg SA , eds. Cancer principles and practice of oncology. Philadelphia: JB Lippincott, 1989: 276–300.

Estey EH Keating MJ McCredie KB Bodey GP Freireich EJ . Causes of initial remission induction failure in acute myelogenous leukemia. Blood 1982; 60: 309–15.

Brandt SJ Peters WP Atwater SK , Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318: 869–76.

Nemunaitis J Singer JW Buckner CD , Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 1988; 72: 834–6.